Cargando…

Rapid systematic review of smoking cessation interventions for people who smoke and have cancer

BACKGROUND: Higher rates of cancer are reported in smokers compared to non-smokers, and continued smoking following a cancer diagnosis is associated with reduced health outcomes and survival. Despite international evidence of increased risks, a substantial percentage of people with a cancer diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Frazer, K, Bhardwaj, N, Fox, P, Niranjan, V, Quinn, S, Kelleher, C, Fitzpatrick, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834964/
http://dx.doi.org/10.1093/eurpub/ckac129.556
_version_ 1784868578019770368
author Frazer, K
Bhardwaj, N
Fox, P
Niranjan, V
Quinn, S
Kelleher, C
Fitzpatrick, P
author_facet Frazer, K
Bhardwaj, N
Fox, P
Niranjan, V
Quinn, S
Kelleher, C
Fitzpatrick, P
author_sort Frazer, K
collection PubMed
description BACKGROUND: Higher rates of cancer are reported in smokers compared to non-smokers, and continued smoking following a cancer diagnosis is associated with reduced health outcomes and survival. Despite international evidence of increased risks, a substantial percentage of people with a cancer diagnosis continue to smoke. Patients may be unaware of the additional risks associated with continued smoking, and health care professionals may not engage with quit supports. As part of a larger feasibility study to develop a smoking cessation pathway in cancer services in Ireland, a rapid review of the evidence was completed. METHODS: Systematic searches of PubMed, Embase, and CINAHL 2015 to December 2020 were conducted; with studies restricted to adults with a cancer diagnosis [lung, breast, cervical, head and neck] and published in English. No restriction was placed on study designs. 6404 studies were identified and uploaded into COVIDENCE platform, Cochrane's systematic review methods were adopted throughout, PRISMA reporting guidelines were used, and narrative data synthesis was completed (CRD 42020214204). RESULTS: The twenty-three-studies report evidence from USA, Canada, England, Lebanon, and Australia. The setting for all interventions was hospitals and cancer clinics. Evidence identifies high dropout rates, inconsistencies in approaches and duration of smoking cessation interventions with varied outcomes. A wide-ranging number of critical components emerged associated with optimal quit support- including the timing of and frequency of quit conversations, use of electronic records, in-person support meetings, provision of nicotine replacement therapy and extended use of Varenicline, smoking cessation services embedded in oncology depts, and engaging with families wanting to quit at the same time. CONCLUSIONS: Developing tailored smoking cessation interventions are needed for smokers diagnosed with cancer to enable engagement. KEY MESSAGES: • Continued smoking following a cancer diagnosis is associated with reduced health outcomes. • Smoking cessation programmes for cancer patient should be tailored to meet needs.
format Online
Article
Text
id pubmed-9834964
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98349642023-01-12 Rapid systematic review of smoking cessation interventions for people who smoke and have cancer Frazer, K Bhardwaj, N Fox, P Niranjan, V Quinn, S Kelleher, C Fitzpatrick, P Eur J Public Health Parallel Programme BACKGROUND: Higher rates of cancer are reported in smokers compared to non-smokers, and continued smoking following a cancer diagnosis is associated with reduced health outcomes and survival. Despite international evidence of increased risks, a substantial percentage of people with a cancer diagnosis continue to smoke. Patients may be unaware of the additional risks associated with continued smoking, and health care professionals may not engage with quit supports. As part of a larger feasibility study to develop a smoking cessation pathway in cancer services in Ireland, a rapid review of the evidence was completed. METHODS: Systematic searches of PubMed, Embase, and CINAHL 2015 to December 2020 were conducted; with studies restricted to adults with a cancer diagnosis [lung, breast, cervical, head and neck] and published in English. No restriction was placed on study designs. 6404 studies were identified and uploaded into COVIDENCE platform, Cochrane's systematic review methods were adopted throughout, PRISMA reporting guidelines were used, and narrative data synthesis was completed (CRD 42020214204). RESULTS: The twenty-three-studies report evidence from USA, Canada, England, Lebanon, and Australia. The setting for all interventions was hospitals and cancer clinics. Evidence identifies high dropout rates, inconsistencies in approaches and duration of smoking cessation interventions with varied outcomes. A wide-ranging number of critical components emerged associated with optimal quit support- including the timing of and frequency of quit conversations, use of electronic records, in-person support meetings, provision of nicotine replacement therapy and extended use of Varenicline, smoking cessation services embedded in oncology depts, and engaging with families wanting to quit at the same time. CONCLUSIONS: Developing tailored smoking cessation interventions are needed for smokers diagnosed with cancer to enable engagement. KEY MESSAGES: • Continued smoking following a cancer diagnosis is associated with reduced health outcomes. • Smoking cessation programmes for cancer patient should be tailored to meet needs. Oxford University Press 2022-10-25 /pmc/articles/PMC9834964/ http://dx.doi.org/10.1093/eurpub/ckac129.556 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Frazer, K
Bhardwaj, N
Fox, P
Niranjan, V
Quinn, S
Kelleher, C
Fitzpatrick, P
Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
title Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
title_full Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
title_fullStr Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
title_full_unstemmed Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
title_short Rapid systematic review of smoking cessation interventions for people who smoke and have cancer
title_sort rapid systematic review of smoking cessation interventions for people who smoke and have cancer
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834964/
http://dx.doi.org/10.1093/eurpub/ckac129.556
work_keys_str_mv AT frazerk rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer
AT bhardwajn rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer
AT foxp rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer
AT niranjanv rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer
AT quinns rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer
AT kelleherc rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer
AT fitzpatrickp rapidsystematicreviewofsmokingcessationinterventionsforpeoplewhosmokeandhavecancer